A detailed history of Israel Englander (Millennium Management LLC) transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 122,752 shares of BTAI stock, worth $89,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,752
Previous 45,124 172.03%
Holding current value
$89,608
Previous $127,000 23.62%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.14 - $2.97 $88,495 - $230,555
77,628 Added 172.03%
122,752 $157,000
Q1 2024

May 15, 2024

SELL
$1.95 - $4.04 $83,512 - $173,021
-42,827 Reduced 48.69%
45,124 $127,000
Q4 2023

Feb 14, 2024

BUY
$2.32 - $5.51 $204,046 - $484,610
87,951 New
87,951 $259,000
Q2 2022

Aug 15, 2022

BUY
$9.03 - $21.55 $1.53 Million - $3.65 Million
169,163 Added 872.65%
188,548 $2.49 Million
Q1 2022

May 16, 2022

BUY
$15.0 - $22.83 $2,025 - $3,082
135 Added 0.7%
19,385 $405,000
Q4 2021

Feb 14, 2022

BUY
$20.12 - $35.09 $387,310 - $675,482
19,250 New
19,250 $391,000
Q2 2021

Aug 16, 2021

SELL
$29.06 - $38.83 $424,188 - $566,801
-14,597 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$39.04 - $64.6 $1.82 Million - $3.01 Million
-46,548 Reduced 76.13%
14,597 $630,000
Q4 2020

Feb 16, 2021

SELL
$42.46 - $56.58 $933,058 - $1.24 Million
-21,975 Reduced 26.44%
61,145 $2.83 Million
Q3 2020

Nov 16, 2020

BUY
$37.44 - $64.63 $1.87 Million - $3.23 Million
49,959 Added 150.66%
83,120 $3.6 Million
Q2 2020

Aug 14, 2020

BUY
$17.62 - $58.71 $584,296 - $1.95 Million
33,161 New
33,161 $1.76 Million
Q2 2019

Aug 14, 2019

SELL
$8.99 - $11.79 $115,692 - $151,725
-12,869 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$3.49 - $10.47 $44,912 - $134,738
12,869 New
12,869 $127,000
Q3 2018

Nov 14, 2018

SELL
$7.51 - $12.99 $343,927 - $594,890
-45,796 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$7.02 - $11.26 $104,647 - $167,852
14,907 Added 48.26%
45,796 $421,000
Q1 2018

May 15, 2018

BUY
$9.83 - $11.03 $303,638 - $340,705
30,889 New
30,889 $316,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $20.5M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.